Inhibition of endocannabinoid-degrading enzymes (fatty acid amide hydrolase and monoacylglycerol lipase [MAGL]) attenuated ARDS in animal models by increasing the concentrations of AEA and 2-AG.19,20. Here, MGLL is linked to acute respiratory distress syndrome.